Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Velocity™ Returns Clean Blood Test

Harness Biotech Rebrands Equine Performance Formula Amidst Blood Test Success


News provided by

Harness Biotechnologies Inc.

Apr 29, 2019, 09:00 ET

Share this article

Share toX

Share this article

Share toX


LOUISVILLE, Ky. and VANCOUVER, Canada, April 29, 2019 /PRNewswire-PRWeb/ -- Harness Biotech is pleased to report that its patent pending 100% natural performance and recovery gel Velocity™ has been independently found risk free for all levels of competitive equine enthusiasts. The blood test was performed by Miller and Associates Veterinarians and third party testing agency Center for Tox Services.

"The results of the blood test definitively show that Velocity passes the most rigorous analysis that are used," says Brad Dieter, PhD, who sits on Harness Biotech's Scientific Board, "We purposefully sought out third-party testers and independent veterinarians to ensure that we had the best possible test. These results, coupled with the high regulated process our product undergoes during manufacturing, are key to showing the world the quality and integrity that Velocity brings to the world of equestrian sports."

“The results of the blood test definitively show that Velocity passes the most rigorous analysis that are used,” says Brad Dieter, PhD, who sits on Harness Biotech’s Scientific Board, “We purposefully sought out third-party testers and independent veterinarians to ensure that we had the best possibl

Post this

Initially launched during Breeders' Cup Week under the name Harness Performance and Recovery Gel, Velocity™ is the only product of its kind; a gel that can distribute Carnosine through topical application. The clean blood test is a particularly significant triumph, as equine events are highly regulated.

Carnosine has been widely studied for its effects on improved wound healing, antioxidant activity and its anti-aging properties since the early 1900s. As the official global rights holder and licensor of the Carnosine complex, Harness Biotech is proud to be the first entity to successfully develop a topical application that directly (and almost immediately) increases levels of Carnosine in the muscle of horses.

"It is reasonable to postulate that the more carnosine in a horse's muscles, the better it will perform," says Dr. Warwick Bayly, a renowned Veterinarian and Professor of Equine Medicine at Washington State University, "At the racetrack even a 1% improvement is huge, that's about 5-6 lengths over a mile, and that's often the difference between winning and losing."

Members of the Harness science and executive team will be in Lexington, Kentucky for Keeneland's 2019 Spring Meet on April 26.

Product available at: https://www.harnessbiotech.com

About Harness Biotechnologies Inc.
A global innovation-driven biotechnology company dedicated to improving equine performance. Harness Biotechnology Inc. researches, licenses, develops and commercializes one-of-a-kind scientific performance and recovery treatments for the equine industry. Harness, is the official global rights holder and licensor of a patent pending one-of-a-kind 100% natural performance and recovery gels for topical application and distribution of Carnosine. Harness products are made in the USA and contain no prohibited substances.

At Harness, we put our products to the test in our barns and on our horses. We back every order with our 100% Happiness Guarantee so that you can shop with confidence. If anything you purchase fails to meet your expectations in any way, just let us know and we'll refund your money right away. 100% Satisfaction Guaranteed!

About Carnosine
Carnosine is a natural and valuable performance and recovery compound for competitive equine athletes, especially those who train at the highest level with high-intensity performance and recovery requirements. Equine athletes whose performances demand serious anaerobic output benefit the most from the use of Carnosine. During high-intensity exercise, acid increases and pH decreases in the muscle tissue, changing the ability of the muscles to perform. Studies have shown that Carnosine prevents the increase in acid and drop in pH, allowing a horse to perform better, for longer. Equine athletes benefit from increased Carnosine concentrations during power and recovery from the Nitric Oxide potentiating properties that it produces. Studies have shown its positive effects on improved wound healing, antioxidant activity, anti-aging properties as well as speeding up recovery time after sports, making Carnosine a valuable tool in increased performance and recovery.

# # #

Media Contact:
David Davies
VP Corporate Communications
Harness Biotech
[email protected]
502-378-3694

SOURCE Harness Biotechnologies Inc.

Related Links

https://www.harnessbiotech.com

Modal title

Velocity
Velocity
Velocity™ Returns Clean Blood Test
View PDF
Velocity™ Returns Clean Blood Test
Velocity™ Handout
View PDF
Velocity™ Handout
Velocity™ at Rolex Grand Prix
Velocity™ at Rolex Grand Prix
Velocity Velocity™ Returns Clean Blood Test Velocity™ Handout Velocity™ at Rolex Grand Prix

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.